Clorexyderm

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clorexyderm

Property Description
Active ingredient Chlorhexidine Gluconate (or Digluconate)
Form Topical Solution, Shampoo, Foam, Gel
Pharmacological class Broad-spectrum Antiseptic Agent
Common purpose Topical Disinfection and Hygiene Maintenance
Origin Synthetic (Cationic Polybiguanide)

What Type of Agent is Clorexyderm?

Clorexyderm is defined as a specialized veterinary preparation whose core function is derived from its active ingredient, Chlorhexidine Gluconate (or Chlorhexidine Digluconate). Pharmacologically, this substance places the product within the Cationic Polybiguanide class, a category of broad-spectrum antiseptic and disinfectant agents that are synthetic in origin and characterized by sustained antimicrobial properties. Chlorhexidine is a surface-active germicide effective against a wide range of microorganisms. The preparation is a combination product, integrating the primary antiseptic with excipients such as Tris-EDTA to support efficacy and conditioners like Glycerine or Lanolin to support skin integrity, which is essential in veterinary dermatology.


Clorexyderm Composition and Available Forms

The active substance, Chlorhexidine Gluconate, is delivered through a range of versatile topical preparations for localized application. These dosage forms include an aqueous solution (spray), a traditional shampoo utilizing a surfactant system, a no-rinse foam, and a concentrated spot gel. This variety is a key differentiating factor, confirming its sole route of administration as topical for dermatological and otological use. The differing physical forms ensure that the product can be applied according to the specific patient need, whether requiring full-body cleansing or targeted, prolonged adherence, optimizing the delivery of the active agent.


What is the General Purpose of Clorexyderm?

The general purpose of Clorexyderm is to provide topical disinfection and support hygiene maintenance by controlling the microbial load on the skin's surface. Its broad-spectrum antimicrobial effect is central to its utility. Chlorhexidine's positive charge allows it to bind to the negatively charged cell walls of pathogens, disrupting their structure. This mechanism is utilized for surface cleansing and skin health maintenance where surface microorganisms require consistent control.

Regulatory References

  1. Chlorhexidine Mechanism of Action (NIH)

What side effects are possible with Clorexyderm?

Possible Side Effects and Safety Information

The safety profile of the active ingredient, Chlorhexidine Gluconate, is structured by regulatory bodies based on the severity and location of potential reactions.

Adverse Reaction Classification

Adverse reactions are primarily grouped within Immune System Disorders and Skin and Subcutaneous Tissue Disorders. Non-serious, local effects may include erythema (redness), irritation, and rash at the application site. However, the most clinically significant concern documented by regulatory agencies is Anaphylactic Reaction (including anaphylactic shock), which is classified as a rare adverse event.

Category Documented Reactions
Local Reactions Irritation, rash, local pain, swelling
Serious Reactions Severe Hypersensitivity, Anaphylactic Shock (Rare)

Safety Restrictions and Special Populations

Official labeling defines strict constraints regarding application to mitigate localized injury and systemic absorption risks. The product is for external use only and must be kept out of the eyes due to the risk of serious and permanent injury. Use is contraindicated in the ear if the tympanic membrane is perforated due to the risk of ototoxicity, and contact with mucous membranes must be avoided.

Regulatory documents highlight the need for caution when the agent is used on premature infants and infants under two months of age, noting the potential for irritation or chemical burns in this specific population. Furthermore, the product is contraindicated in any individual with a known allergy to Chlorhexidine Gluconate.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for accidental overdose of Chlorhexidine Gluconate, the active ingredient in Clorexyderm, is defined by two primary documented risks that require immediate attention.

Accidental Ingestion and Manifestations

Overdose following the accidental swallowing of the liquid solution may result in documented clinical manifestations related to the gastrointestinal system, including gastric distress, nausea, and gastritis. If a sufficiently large volume of an alcohol-containing formulation is ingested, signs of alcohol intoxication may also be a concern. In these cases, contacting a Poison Control Center right away is the mandated emergency action. Supportive and symptomatic treatment, including the potential for gastric lavage, is the management approach documented in regulatory sources. No specific antidote is officially known.

Life-Threatening Allergic Reactions

A more serious, though very rare, risk is the documented potential for a life-threatening anaphylactic reaction (anaphylaxis or shock) following exposure. Symptoms that require immediate action include difficulty breathing, facial swelling, hives, or wheezing. In such scenarios, use must be stopped immediately, and emergency medical help must be sought right away.

Population-Specific Considerations

Regulatory warnings exist for small children regarding specific volumes of ingestion, as well as for premature infants concerning the potential for irritation or chemical burns from topical application.

Therapeutic Uses of Clorexyderm

Clorexyderm is applied across domains where additional symptomatic support is needed in veterinary dermatology, commonly used across conditions characterized by periods of heightened symptoms related to microbial imbalances. It is utilized in addressing conditions presenting with symptoms of microbial imbalances, such as those seen in pyoderma or Malassezia dermatitis.

It is relevant for easing symptom clusters that may become intense or disruptive, including physical discomfort symptoms like pruritus (itching) and erythema (redness). It is also used for managing symptoms associated with malodorous skin and excessive seborrhoeic scale, and is often used during phases when symptoms become more noticeable.

This supportive care contributes to easing the overall symptom load and may help patients cope more steadily when symptoms interfere with daily functioning.

Quick Fact: Relief for Pruritus and Odor Clorexyderm supports the patient during difficult episodes and contributes to improved comfort during periods of heightened symptoms related to itching and malodour.

Regulatory References

  1. U.S. Food and Drug Administration (FDA) DailyMed listing

Eligibility and Restrictions for Use

The eligibility profile for Clorexyderm is defined by veterinary regulatory labeling, as it is an animal medicinal product containing Chlorhexidine Digluconate. The product is intended for use exclusively on the established target species: dogs and cats.


Absolute Non-Eligibility

Use is contraindicated in animals with known hypersensitivity to the active substance (Chlorhexidine) or to any of the product's excipients. As documented by regulatory authorities, the product is strictly for veterinary use only, making it prohibited for human use.


Populations Requiring Conditional Use

Use of the product is restricted and requires formal veterinary consultation for several populations, reflecting situations where safety data is conditional or not fully established:

  • Age: Safety has not been demonstrated in animals under five months of age, and use in all young animals, including puppies and kittens, requires professional guidance.
  • Health Status: Sick or convalescent animals must be evaluated by a veterinarian before use.
  • Reproductive Status: Pregnant, lactating, and breeding animals are conditional populations, requiring a formal veterinary benefit/risk assessment prior to application.

This eligibility profile ensures that only healthy, non-sensitive, adult target species are eligible for standard use, while all restricted populations must proceed under the direction of a veterinarian.

What should I know about interactions with other medicines?

The interaction profile for Clorexyderm, a topical antiseptic, is defined exclusively by local effects at the application site, reflecting its negligible systemic absorption. Regulatory documentation outlines specific use restrictions based on chemical incompatibility and local pharmacodynamic risks.

Chemical Incompatibility: The primary restriction is the prohibition of co-administration with anionic substances, which include anionic soaps and anionic detergents. Chlorhexidine, the cationic active ingredient, is chemically incompatible with these anionic agents. This interaction causes a neutralization of the antiseptic, resulting in the immediate inactivation or significant reduction of its intended antimicrobial activity. This is a crucial restriction necessary for preserving the product's efficacy.

Pharmacodynamic Interactions: Regulatory cautions also address the co-use of Clorexyderm with other topical antiseptic preparations. Such combinations may lead to additive local effects, increasing the documented risk of localized skin irritation or sensitization.

Systemic Interaction Profile: Given the product's topical route and minimal concentrations in the bloodstream, official labeling does not specify any clinically relevant systemic pharmacokinetic interactions. Therefore, warnings regarding co-administration with other medications related to metabolic pathways (like CYP enzymes), drug transporters, food, or alcohol are absent from regulatory documentation.

Mechanism of Action

How Clorexyderm Works: Mechanism of Action

Clorexyderm operates through its active component, chlorhexidine digluconate, a compound that exerts its primary action by disrupting the structural integrity of microbial cells. This is initiated by the molecule's cationic (positively charged) nature, which is attracted to and rapidly binds with the negatively charged surface components of microbial cell membranes (in both bacteria and yeasts).

This electrostatic binding alters membrane permeability, leading to structural damage and the creation of small pores. This immediate physical breach causes essential low-molecular-weight materials, such as potassium ions, to leak out. Furthermore, at effective localized concentrations, the component penetrates the cell, causing the coagulation of intracellular proteins and nucleic acids. This cascade of structural failure and internal component precipitation is the physiological consequence that results in the inactivation of the targeted microorganisms.

Following application, the component binds tightly to keratin in the skin's outermost layer. This binding establishes a local reservoir, resulting in the prolonged localized presence of the active molecule, which continues to restrict microbial attachment and proliferation.

Dosage and Administration Information

The administration of Clorexyderm, which utilizes Chlorhexidine Digluconate (or Gluconate), is governed by the specific format of the product, with the route of administration strictly topical for dermatological application, and otological for the ear canal.


Administration Scope

Instruction Detail
Route of administration Topical (dermatological) and Otological (ear canal).
Dosing schedule The volume applied varies; shampoo typically ranges from 10 mL to 50 mL, adjusted according to the animal's weight/size and coat length to ensure thorough coverage.
Frequency and schedule Use follows a cyclic/tapering pattern. Initial intensive use may be two to three times per week for several weeks, gradually reducing to once weekly for long-term hygiene maintenance, or as directed by the prescribing veterinarian.
Preparation requirements Shampoo requires the coat to be thoroughly wetted before application and requires rinsing. Solution/Foam is a ready-to-use formula and is typically not rinsed off.

Resulting Procedural Structure

For the shampoo format, a specific contact time of 5 to 10 minutes is required after lathering and before rinsing with clean water. For all forms, it is essential that the animal be prevented from licking the treated area during the application and drying process. The product is not for use on animals with a non-intact eardrum or simultaneously with other disinfectants.

These established conditions and frequencies govern the proper administration of the product by defining a standardized topical route and application method based on the specific formulation.

Recent Clinical Evidence

Clorexyderm: Recent Clinical Evidence

Clinical evidence regarding the active ingredient in Clorexyderm, chlorhexidine digluconate (CHX), primarily focuses on its broad-spectrum antimicrobial properties against various bacteria and yeasts. Research generally investigates its use as a topical antiseptic for skin and wound cleansing.

Efficacy and Study Context

Studies have evaluated the effectiveness of CHX-containing formulations across different clinical contexts, often comparing them against other antiseptic agents.

  • Infection Control: Research supports the role of CHX-containing dressings and solutions in surgical site preparation and in settings where reducing hospital-acquired infections, such as those related to external ventricular drains (EVDAIs), is critical. One 10-year study reported that the introduction of CHX dressings was associated with a significant reduction in the occurrence of EVDAIs.
  • Antimicrobial Activity: Laboratory and in vitro studies indicate that CHX is highly effective against Gram-positive bacteria, though higher concentrations may be required for Gram-negative bacteria and fungi. The effectiveness is influenced by the concentration and formulation used, with some research comparing 4% CHX preparations to other cleansing agents for immediate and persistent antimicrobial activity on the skin.

Safety and Tolerability

While studies frequently report CHX formulations to be generally well-tolerated in topical applications, some clinical trials have observed adverse reactions. These are typically mild and localized to the application area.

Observed reactions may include:

Observation
Pruritus (itching)
Erythematous reactions (redness)

In most cases, these minor reactions did not require stopping the treatment and often resolved without specific intervention. Research continues to investigate formulations that maintain efficacy while improving patient acceptance and minimizing potential side effects.

Key Studies & References

  1. Antiseptics and Disinfectants: Activity, Action, and Resistance
  2. Surgical site infection: prevention and treatment (NICE Guideline NG125)

Frequently Asked Questions (FAQ)

Common questions about Clorexyderm (FAQ)


Q: What is the difference between Clorexyderm Foam, Shampoo, and Spot Gel formulations?

The different formulations are designed for specific application needs. The shampoo is generally intended for intensive, full-body cleansing, while the spray, foam, and spot gel forms are more suited for targeting localized skin areas or for use in maintaining hygiene in between bathing schedules. Official product information describes the products' intended use based on their format.

Q: Does Clorexyderm work against both bacterial and fungal skin problems?

Official product information confirms that the active ingredient is a broad-spectrum antiseptic. This means that the product is confirmed to have activity against a wide range of microbial pathogens, including both bacteria and yeasts/fungi, which are common causes of skin issues.

Q: Are the reported side effects for Clorexyderm common or rare?

Localized adverse reactions, such as irritation or redness at the application site, are generally reported as mild and often temporary. In contrast, serious systemic reactions, such as anaphylaxis, are classified by regulatory agencies as rare events.

Q: Can accidental contact with the eyes or mouth cause issues when using Clorexyderm?

The product information strictly advises avoiding contact with the eyes, as accidental exposure can cause serious and permanent injury. While contact with oral tissues or mucous membranes must be avoided, high exposure has been known to cause issues such as temporary irritation or an altered sense of taste.

Q: Can Clorexyderm be safely applied to the face, near the eyes, or around the mouth?

Regulatory guidance advises extreme care when applying the product near the face and head, as it must not be allowed to migrate into the eyes. Some official texts indicate that the product may be restricted for use as a preoperative skin preparation on the face, and contact with mucous membranes must be strictly avoided.

Q: Is the shampoo meant for all-over body cleansing or only for localized problem areas?

The shampoo format is typically recommended for generalized skin problems and full-body cleansing. The instructions for use involve adjusting the volume based on the body size and coat length to ensure thorough coverage. For smaller, localized issues, the spray or foam preparations are often recommended instead.

Q: Why is it advised to prevent animals from licking the treated area immediately following application?

The instruction to prevent licking is provided to mitigate the risk of ingestion. While the product has low absorption through the skin, swallowing large doses has been associated with gastrointestinal or other adverse effects in animals, and the instruction helps prevent this ingestion risk.

Q: What research evidence exists regarding Clorexyderm's effectiveness against yeasts like Malassezia?

The product is officially labeled as an antifungal and is used to help manage yeast on the skin. Veterinary resources specifically cite the use of the active ingredient for complementing the treatment of skin conditions, including those caused by Malassezia yeast.

Q: Are there any long-term safety concerns regarding prolonged or chronic exposure to chlorhexidine?

Official documents from regulatory and safety data sources address the issue of long-term exposure. Animal studies involving concentrated forms and high doses have indicated the potential for repeated exposure to cause organ damage. Furthermore, chronic topical use has been documented to cause irritant contact dermatitis.

Q: How does the concentration of chlorhexyderm in Clorexyderm relate to its intended use?

The official product range utilizes a consistent 4% concentration of chlorhexidine digluconate across its shampoo, spray, and foam formulations. The choice between formats is based on the intended application method—whether it is for generalized cleansing or targeted, localized use—rather than a difference in active ingredient concentration.

Q: What is the potential for staining or discoloration of the skin or fur when using Clorexyderm?

Staining or discoloration is a potential consideration for the active ingredient. While the product is topical, oral preparations have been documented to cause temporary staining of the teeth and tongue. Staining of the fur has also been noted in animal studies when high doses were ingested.

Q: Is Clorexyderm suitable for use on open cuts or deep skin wounds?

The product is generally used for skin cleansing and wound care. However, some regulatory labels for the ingredient caution against use on wounds that involve more than the superficial layers of skin. Use should be restricted based on the wound's severity and professional guidance.

Q: What is the procedure if a large amount of Clorexyderm is accidentally swallowed or ingested?

In the event the product is accidentally swallowed, official safety data sheets state that vomiting is not to be induced. Immediate medical help is required, or a Poison Control Center should be contacted right away for further guidance.

Q: Is it possible to develop a temporary tingling sensation or strange taste when using chlorhexidine-based oral rinses?

The active ingredient, chlorhexidine gluconate, is used in some oral rinses, and its use is associated with a commonly reported side effect. This may include a temporary alteration in taste perception or a tingling sensation.

Q: What should be done if Clorexyderm accidentally contacts the eye?

If accidental eye contact occurs, the regulatory safety guidance is to promptly and thoroughly flush the eye with clean water. Following irrigation, medical advice from an ophthalmologist is required immediately due to the risk of serious injury.

Q: Can Clorexyderm be used safely in sensitive areas such as skin folds or interdigital spaces?

Caution is strongly advised when applying the product to sensitive areas such as skin folds or between the toes. Regulatory documents indicate that the solution should not be allowed to pool in skin folds due to the potential risk of causing local irritation or chemical burns.

Q: Does the Clorexyderm formulation contain any known ingredients that are common allergens?

The product is contraindicated if there is a known hypersensitivity to the active substance or to any of its excipients (inactive ingredients). Safety data indicates that certain excipients found in chlorhexidine products are known to cause skin and eye irritation or sensitization.

Q: Can Clorexyderm help manage secondary symptoms like hair loss or greasy skin associated with microbial overgrowth?

The product is included in treatment protocols designed to manage skin conditions associated with microbial overgrowth. By targeting the underlying bacterial and fungal load, it can help manage secondary symptoms, which may include greasy skin (seborrhea oleosa) or hair loss caused by the infection.

Q: What are the recommended safety precautions for the person applying Clorexyderm to minimize exposure?

Recommended safety precautions for the person applying the product are provided in official safety data sheets. These generally include the need for thorough washing of the skin after handling the product and the use of safety equipment such as eye protection and chemical-resistant gloves.

How should Clorexyderm be stored and disposed of?

Storage and Disposal Requirements

Clorexyderm and related chlorhexidine products require specific storage conditions to maintain stability, as dictated by regulatory labeling. The product must be stored at room temperature and not be refrigerated (below 8 C). Storage areas should offer protection from heat, light, and moisture.

Storage Constraint Requirement
Container Integrity Keep the container tightly closed and store in its original packaging.
Stability After Opening Use some liquid formulations within 2 months after first opening.
Child Safety Keep the product out of the sight and reach of children and pets.

Disposal of unused or expired product and waste materials must be performed in accordance with local requirements for veterinary medicinal products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clorexyderm found in:

A-Z Index: